Compare PRKS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRKS | BCRX |
|---|---|---|
| Founded | 1959 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2012 | 1995 |
| Metric | PRKS | BCRX |
|---|---|---|
| Price | $32.64 | $9.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $47.00 | $20.82 |
| AVG Volume (30 Days) | 792.9K | ★ 5.9M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ 3.06 | 1.21 |
| Revenue | ★ $1,263,324,000.00 | $25,186,000.00 |
| Revenue This Year | $3.70 | N/A |
| Revenue Next Year | $3.19 | $12.55 |
| P/E Ratio | $10.10 | ★ $7.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.77 | $6.00 |
| 52 Week High | $56.95 | $11.31 |
| Indicator | PRKS | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 64.59 |
| Support Level | $29.85 | $7.85 |
| Resistance Level | $33.75 | $10.32 |
| Average True Range (ATR) | 1.42 | 0.60 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 81.12 | 65.44 |
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.